Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Scientists created cell lines to study a genetic skin disorder using CRISPR technology.

5α-reductases increase epitestosterone's effect on androgen receptors.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Finasteride dosages should be adjusted based on CYP3A5 genotype and liver function to avoid side effects.

Different forms of FGF5 either promote or inhibit hair growth.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

The K14 promoter is more active in skin cells than the K5 promoter.

A genetic variant in goats is linked to cashmere growth.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

Genomic profiling for myeloid cancers can find important inherited mutations, but it's challenging when these mutations aren't related to the patient's symptoms.

The compound 4c showed strong potential as an anticancer agent.

Anagen grow may effectively treat hair loss by blocking testosterone and reducing enzyme activity.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

A new method creates precise, stable microscale structures with reduced friction and potential for complex designs.

No link found between specific genes and female pattern hair loss.

The document's conclusion cannot be provided because the document is not available or cannot be read.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

Improving CRISPR/Cas systems can make gene editing more efficient and precise.

Mouse skin cells can become sperm-like cells in the lab.

Improved CRBN ligands make protein degraders more effective and drug-like.

Genosomes are promising for safe and effective gene delivery in therapy.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

A new method creates unique chemical structures that could improve drug discovery.